Skip to content
Pre-epileptic medicine for the treatment of epilepsy and anxiety


Important note: This medicine is a medicinal product, the ingredients in it cause many side effects or interfere with the action or effect of many other medicines, therefore, consult a doctor or pharmacist before taking this medicine and read the instructions written in the attached leaflet and stick to the appropriate dose for your condition . If you experience any symptoms, stop taking the medicine immediately and inform your doctor.


Pregabalin is a medicine used to treat epilepsy, and it can also be used to treat nerve pain and anxiety.


Briquaplin is prescribed to treat the following conditions:

  • Partial epileptic seizures.
  • Central or peripheral nerve pain.
  • Generalized anxiety disorder.


Broncapine can cause side effects such as dizziness and drowsiness. These effects can increase the risk of accidental falls in elderly patients, so care should be taken.

The drug should be used with caution in patients with cardiovascular disease, especially if they are elderly, because it can cause heart failure.

There was an increase in suicidal thoughts in patients taking pregaplin. If these symptoms occur, you must immediately inform your doctor.

Patients with a history of alcohol abuse or drug abuse should inform their physician before taking rifapiline.

Priqaplin should not be used to treat children and adolescents under 18 years of age.

Alcohol should not be consumed during treatment with pregabalin.

Prunitabine may cause effects that reduce the ability to drive and use machinery, therefore, such activities should be avoided.


Some of the side effects caused by brinjaplin – such as dizziness, drowsiness and decreased concentration – may increase if you take other medicines with it such as:

  • Oxycodone (an opioid analgesic)
  • Lorazepam (a benzodiazepine used to treat anxiety).
  • Alcohol.

In general, inform the doctor if you are taking, or have recently taken, any type of medication, including medications, herbs and supplements.

side effects

Prunapilin can cause various side effects, although not every patient appears. It depends on each person’s sensitivity to the drug.

The main negative effects that may occur during treatment with brinapiline are listed below.

Nervous system disorders

Priqaplin can cause:

  • Drowsiness
  • Numbness.
  • Lethargy.
  • Dizziness
  • Headache.
  • Shivering.
  • Poor memory.
  • Difficulty speaking.
  • Tingling sensation.
  • Insomnia.
  • Exhaustion.
  • Dizziness and balance disorders.
  • Abnormal gait
  • cramps.

psychiatric disturbances

Priqaplin can cause:

  • Confusion.
  • Decreased or increased sexual desire.
  • Insomnia.
  • Depression.
  • Hallucinations.
  • Abnormal dreams
  • Panic attacks.
  • carelessness.
  • Aggressiveness.
  • Feeling of euphoria.
  • Difficulty thinking.

Eye disorders

Treatment with Regaplin can cause changes in vision and around vision loss, mydriasis, dry eyes, swollen or painful eyes, and irritation.

Cardiovascular disease

Treatment with piercing can cause heart rhythm disturbances, low or high blood pressure, and heart failure.

Metabolic and Nutritional Disorders

You may experience an increase or loss of appetite, gain or loss of weight and an increase or decrease in blood sugar levels during.

Digestive disorders

Treatment with breclipline can cause nausea, vomiting, diarrhea or constipation, flatulence, bloating, and pancreatitis.

Lung and respiratory disorders

Treatment with recapilin can cause difficulty breathing, a dry nose, sore throat, cough, and fluid collection in the lungs.

Disorders of the reproductive system and breasts

Treatment with breclampin can cause erectile dysfunction, delayed ejaculation, breast development in men (gynecomastia) , menstrual pain in women and abnormal breast growth.

Kidney and urinary tract disorders

Treatment with breclampin may cause difficulty or pain with urination and urinary incontinence.

Changing diagnostic test results

Treatment with brigaplin may cause an increase in certain substances in the blood, such as creatine and creatinine.

Other side effects

Other side effects that may occur during treatment with bridgaplin are:

  • Allergic reactions in sensitive people.
  • Dry mouth.
  • Arthritis.
  • Swelling in the joints
  • Muscle cramps.
  • Muscle pain.
  • Loss of sense of taste.
  • Fainting.
  • Troubled hearing (hypersensitivity and intolerance to sounds).
  • skin Sensitivity.
  • General weakness.
  • Increased thirst


Symptoms that may appear when taking too much of the medicine regapiline are drowsiness, confusion, and insomnia.

If an overdose is suspected, you should immediately contact a doctor and go to the nearest hospital.

Mechanism of Action

Bridgapiline works by binding to voltage-dependent calcium channels in the central nervous system.

In this way, bridgaplin can reduce the release of certain neurotransmitters such as:

  • Glutamate (the main neurotransmitter in the brain).
  • Substance, a vasodilating polypeptide, is involved in many biological processes, including pain and vomiting.

Method of use – dosage

Recapiline is available as a medicine to take by mouth (hard capsules or syrup).

The doctor must determine the dose of brinjaplin on a case-by-case basis.

In general, the dosage ranges from 150 to 600 mg daily.

It would be a good idea to take your medicine at the same time every day.

For patients with kidney disease, a reduction in the dose of brigapiline is usually required.

Pregnancy and breast-feeding

Preclipse should not be taken during pregnancy unless your doctor considers it absolutely necessary.

Women of childbearing age who are taking the medicine regapiline should take adequate precautions to prevent pregnancy.

It is not known whether bridgaplin passes into breast milk, therefore, it should not be taken during breastfeeding.

Contraindications to use

It is prohibited to use the medicine breclipline in the following cases:

  • Hypersensitivity to pregabalin.
  • While breastfeeding.



Leave a Reply

Your email address will not be published. Required fields are marked *